Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis
15 out of 18 complete responders (83%) demonstrate continued complete response with median follow-up of 36 months Reduction in surgeries compared to year prior to... Read more.
Pelican Provides Advanced Protective Cases for Next Generation Squad Weapons at AUSA 2025
Protecting the U.S. Military’s NGSW Program with Mission-Ready Protective Transit Solutions TORRANCE, Calif., Oct. 13, 2025 /PRNewswire/ — Pelican Products,... Read more.
NetActuate Supports Raleigh-Durham-Chapel Hill Triangle with Investments in Technology Access and Education
RALEIGH, N.C., Oct. 13, 2025 /PRNewswire/ — NetActuate, a global provider of network and infrastructure services, is proud to reaffirm its commitment to the... Read more.
Level Education Group Acquires Triad to Transform the Educational and Professional Pathway for Behavioral and Mental Health Professionals
SOUTH JORDAN, Utah, Oct. 13, 2025 /PRNewswire/ — Level Education Group, LLC (“LEG”), a leader in continuing education for mental health and nursing... Read more.
Shield AI and Parry Labs Announce Strategic Collaboration to Deliver Integrated Autonomy at the Edge
WASHINGTON, Oct. 13, 2025 /PRNewswire/ — Shield AI and Parry Labs today announced a Memorandum of Understanding (MoU) to integrate advanced autonomy with edge... Read more.
StoryOne: Human-Centric AI Publishing launches ahead of Frankfurt Book Fair 2025
VIENNA, Oct. 13, 2025 /PRNewswire/ — Next Wednesday (October 15) marks the official start of the Frankfurt Book Fair – and the Vienna-based start-up StoryOne... Read more.
Vertiv Names Craig Chamberlin as Chief Financial Officer
COLUMBUS, Ohio, Oct. 13, 2025 /PRNewswire/ — Vertiv Holdings Co (NYSE: VRT), a global leader in critical digital infrastructure, today announced the appointment... Read more.
Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting
Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to be presented... Read more.
AI-Powered Video Analytics Market to Reach $42.2 Billion by 2034 Globally, at 18.3% CAGR: Allied Market Research
The global AI-powered video analytics market is experiencing rapid growth due to rising demand for seamless digital surveillance infrastructure, increasing adoption... Read more.
A Glimpse into the Future of “People, Cars and Life”: The 2025 Chery International User Summit Set to Open
WUHU, China, Oct. 13, 2025 /PRNewswire/ — As the global automotive industry rides the wave of a once-in-a-century transformation, a new era marked by openness... Read more.